FDAnews Device Daily Bulletin

Insulet Hires New Executive Vice President and Chief Financial Officer

Jan. 11, 2019

Insulet has appointed Wayde McMillan as its new executive vice president and CFO, succeeding Michael Levitz, who will temporarily stay on with the company in an advisory role.

McMillan most recently served as CFO and vice president of finance for Medtronic’s minimally invasive therapies group, playing a big part in integration efforts after the company acquired Covidien in 2015.

In his prior role at Medtronic, McMillan managed an $8 billion revenue business with more than 20,000 employees and a global financial team.

View today's stories